PubRank

Albrecht Stenzinger

Author PubWeight™ 45.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 2012 4.30
2 Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol 2013 4.11
3 Noncompaction myocardium in association with type Ib glycogen storage disease. Pathol Res Pract 2012 1.41
4 KRAS genotyping of paraffin-embedded colorectal cancer tissue in routine diagnostics: comparison of methods and impact of histology. J Mol Diagn 2009 1.38
5 Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing. J Mol Diagn 2013 1.37
6 BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood 2012 1.36
7 Detection and segmentation of cell nuclei in virtual microscopy images: a minimum-model approach. Sci Rep 2012 1.35
8 Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas. Eur Respir J 2012 1.17
9 ROS1 expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 cases. Histopathology 2014 1.10
10 Correlation of radio- and histomorphological pattern of pulmonary adenocarcinoma. Eur Respir J 2012 1.10
11 Re: "Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course". J Natl Compr Canc Netw 2016 1.08
12 Potential clinical implications of BRAF mutations in histiocytic proliferations. Oncotarget 2014 1.07
13 Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach. Virchows Arch 2012 1.07
14 Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment. Clin Cancer Res 2011 1.04
15 Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer. Histopathology 2012 1.04
16 Postoperative complications deteriorate long-term outcome in pancreatic cancer patients. Ann Surg Oncol 2011 1.03
17 Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification. Virchows Arch 2012 1.01
18 CognitionMaster: an object-based image analysis framework. Diagn Pathol 2013 1.00
19 Who is at risk for diagnostic discrepancies? Comparison of pre- and postmortal diagnoses in 1800 patients of 3 medical decades in East and West Berlin. PLoS One 2012 0.98
20 Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer. Hum Pathol 2010 0.95
21 Distinctive Spatiotemporal Stability of Somatic Mutations in Metastasized Microsatellite-stable Colorectal Cancer. Am J Surg Pathol 2015 0.95
22 Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway. Hepatology 2013 0.91
23 EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype. Eur Respir J 2013 0.91
24 Clinical and molecular characteristics of HNSCC patients with brain metastases: a retrospective study. Eur Arch Otorhinolaryngol 2013 0.90
25 Fibroblast growth factor receptor 1 as a putative therapy target in colorectal cancer. Digestion 2013 0.89
26 mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer 2011 0.88
27 KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma. Pancreas 2014 0.87
28 Follicle-stimulating hormone receptor expression in soft tissue sarcomas. Histopathology 2013 0.87
29 Survival of patients with oral cavity cancer in Germany. PLoS One 2013 0.85
30 Prognostic impact and clinicopathological correlations of the cribriform pattern in pulmonary adenocarcinoma. J Thorac Oncol 2015 0.85
31 Absence of BRAF and KRAS hotspot mutations in primary mediastinal B-cell lymphoma. Leuk Lymphoma 2014 0.83
32 DNA index as a strong prognostic factor in patients with adenocarcinoma of the pancreatic head: results of a 5-year prospective study. Pancreas 2013 0.83
33 Unmasked: when a clinically malignant disease turns out infectious. A rare case of tularemia. Int J Surg Pathol 2012 0.82
34 In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model. Radiat Oncol 2012 0.81
35 Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness. Pathobiology 2011 0.81
36 Expression of PTPIP51 during mouse eye development. Histochem Cell Biol 2007 0.79
37 Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma. Medicine (Baltimore) 2016 0.79
38 DNA index is a strong predictive marker in intrahepatic cholangiocarcinoma: the results of a five-year prospective study. Surg Today 2013 0.79
39 High nuclear poly-(ADP-ribose)-polymerase expression is prognostic of improved survival in pancreatic cancer. Histopathology 2012 0.79
40 Ataxia-telangiectasia-mutated protein kinase levels stratify patients with pancreatic adenocarcinoma into prognostic subgroups with loss being a strong indicator of poor survival. Pancreas 2015 0.78
41 Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer. Pathobiology 2012 0.78
42 PTPIP51 mRNA and protein expression in tissue microarrays and promoter methylation of benign prostate hyperplasia and prostate carcinoma. Prostate 2009 0.78
43 Profiling of cMET and HER Family Receptor Expression in Pancreatic Ductal Adenocarcinomas and Corresponding Lymph Node Metastasis to Assess Relevant Pathways for Targeted Therapies: Looking at the Soil Before Planting the Seed. Pancreas 2016 0.76
44 Qualitative Comparison Between Carrier-based and Classical Tissue Microarrays. Appl Immunohistochem Mol Morphol 2017 0.75